CBSE private candidates exam 2021: Admit cards released for Class 10, 12; check direct link here

-

The Central Board of Secondary Education (CBSE) has put out the admit cards for the Class 10 and 12 private candidates. The exams will be held from 25 August to 8 September for Class 10. For Class 12, the exams will go on till 15 September.

The process to download the admit card for private candidates is as follows:

- Visit the official website of the CBSE - https://www.cbse.gov.in/

- Click on the ‘New Website’ option. A new page will open

- Click on the ‘E-Pariksha’ link given below on the page

- Select the link for generating admit cards for private candidates

- Choose the credential type and log in by entering the required details

- Click on submit. The hall ticket will be displayed online

Here’s the direct link:

https://cbseit.in/cbse/web/pvtform/pvtAdmCard.aspx

The CBSE will hold the exams for private candidates together with the improvement examinations. Students who want to improve their results, candidates registered in the ‘special subjects’ category, second chance compartment candidates of 2019 and 2020, and failed students of previous years are also eligible to appear in the examinations.

The exams will be held offline, despite opposition from students. The board has said that the means of alternative assessment that was used for regular students will not be available for private candidates, since it does not have accurate data available to prepare the results using any other method.

https://www.news18.com/news/india/cbse-private-compartment-exams-admit-cards-released-steps-to-download-cbse-nic-in-4110242.html

The CBSE had cut the exam syllabus by 30 percent earlier. The paper will also have more Multiple Choice Questions (MCQs).

The exams will be held from 10:30 am to 1:30 pm on the mentioned dates. The other details, such as venue and subject, will be mentioned on the hall tickets. Students need to bring a printout of the ticket to the exam venue.

Keywords: 



from Firstpost India Latest News https://ift.tt/3D4Ar8O
FP Trending

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

Aditya L1 Mission: Spacecraft is nearing its final phase, says ISRO chief

-
Aditya L1 spacecraft is nearing its final phase, and manoeuvres to enter the L1 point are expected to be completed by January 7, 2024, according to ISRO Chairman S Somanath. “Aditya is on the way. I think it has reached almost its final phase,” the ISRO chief told PTI on the sidelines of an event organised at VSSC to commemorate the 60th year of the First Sounding Rocket Launch. Aditya L1, India’s first space-based mission to study the Sun, was successfully launched on September 2 from the Satish Dhawan Space Centre (SDSC) in Sriharikota. The spacecraft, after travelling about 1.5 million km from Earth over 125 days, is expected to be placed in a Halo orbit around the Lagrangian point L1, considered closest to the Sun. He said that the last preparations for the spacecraft’s entry into the L1 point are currently underway incrementally.”Possibly by January 7th, the final manoeuvres will be done for entering into the L1 point,” Somanath added. Among other tasks, it will capture and tr
Read more